Asord Uses, Dosage, Side Effects and more
Asord is a vitamin D(3) analogue which has not caused hypercalcaemia or significant irritation in preclinical trials.
Asord (formerly QRX-101) is a novel vitamin D analogue for the treatment of mild to moderate psoriasis. In clinical and preclinical studies, becocalcidiol has been well tolerated with a low incidence of skin irritation. Based on the completed Phase IIb study, becocalcidiol was statistically superior to placebo in reducing plaque and did not result in excessive blood calcium levels, a side effect of existing calcitriol topical treatments for psoriasis.
| Trade Name | Asord |
| Generic | Becocalcidiol |
| Becocalcidiol Other Names | Becocalcidiol |
| Type | |
| Formula | C23H36O2 |
| Weight | Average: 344.5307 Monoisotopic: 344.271530396 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
For topical treatment of psoriasis and psoriatic disorders.
How Asord works
The mechanism of action of becocalcidiol in the treatment of psoriasis is accounted for by an antiproliferative activity for keratinocytes and the stimulation of epidermal cell differentiation.
